Medication Safety Communication: Sodium Chloride 0.9% 100 mL Intravenous Solution

This document is about sodium chloride 0.9% 100 mL intravenous solution, which is manufactured by Baxter and Freeflex. The product is used for correcting hydration deficits and electrolyte imbalances.


Medication Safety Communication: Sodium Chloride 0.9% 100 mL Intravenous Solution - cover page
Category
Other
Document type
Other
Language
English
Pages
2
File format
PDF
File size
217 KB
Published
17 November, 2023
Updated
17 November, 2023
MD5 checksum
0CCB8987687A41A719B905417CEE2F13

About this manual

This document is a Medication Safety Communication intended as a guide for health professionals in NSW public health organizations. It addresses a disruption in the supply of Baxter® and Freeflex® sodium chloride 0.9% 100 mL intravenous solutions due to manufacturing issues and increased demand, with an unclear estimated resolution date. The document advises facilities to continue ordering regular brands from their usual suppliers unless advised otherwise and to reserve existing stock for fluid-restricted patients.

What's inside

  • What's new in this update
  • Main indications and use
  • Situation
  • Alternative agents
  • International alternatives
  • Precautions, safety issues and other considerations
  • Impacts of this communication on clinical practice
Download PDF (217 KB)

Also Manuals